By Brad MacLiver
Authorship and profile at Google
The U.S. Department of Health and Human Services provides a program for discounted prescription drugs to qualified Federally Qualified Health Centers (FQHC), Disproportionate Share Hospitals (DSH), and other qualified entities. When these facilities don’t have their own pharmacies they are allowed to contract with a local pharmacy. The drug pricing program is often referred to as 340B, named after the section of the law that established the program.
Authorship and profile at Google
The U.S. Department of Health and Human Services provides a program for discounted prescription drugs to qualified Federally Qualified Health Centers (FQHC), Disproportionate Share Hospitals (DSH), and other qualified entities. When these facilities don’t have their own pharmacies they are allowed to contract with a local pharmacy. The drug pricing program is often referred to as 340B, named after the section of the law that established the program.
Pharmacies
can be contracted by a FQHC, or similar 340B qualified entity, to manage and
dispense the medications. Patients from these entities provide additional
traffic in the pharmacies allowing the pharmacies the opportunity for
additional front end sales along with the Rx sales.
Pharmacy
owners participating in a 340B pharmacy program need to manage their business
consistent with customary business practices. In the event of an audit the
pharmacy should have dispensing and inventory records, billing statements, etc.
Business records should show that drugs purchased by customers, under the 340B
Drug Pricing Program, were not diverted to people who are not part of the program.
Along
with the additional record keeping a pharmacy owner will need employees who
understand the various state and federal rules and regulations, which govern
the 340B program. The pharmacy will also need to have a location for the 340B
inventory, which is separate from their normal inventory, or have a software
management system to track the separate inventories.
A
system of separating the inventory is required due to the drug inventory used
for the 340B pharmacy program is owned by entity that contracted the pharmacy.
Since the 340B inventory is not “owned” by the pharmacy this inventory will be
treated differently for tax purposes. The pharmacy generates income from
dispensing fees they are paid instead of a mark-up or profit margin on the
inventory.
Since
customers participating in a 340B program can only purchase the designated
medications from a pharmacy contracted with a 340B entity, this allows a
pharmacy to have a market niche. A contracted pharmacy servicing 340B customers
benefit from additional customer traffic visiting the store.
With
the current economic situation and high unemployment, many people have lost
their insurance benefits. This will likely expand the need for 340B pharmacy
programs and provide additional 340B customers to a participating pharmacy.
However,
when a pharmacy owner is weighing the potential benefits of a 340B program,
they should also consider other aspects of their business and the current
market conditions of the pharmacy industry. What are the pharmacy’s goals over
the next couple years? A younger pharmacy owner with long term objectives can
benefit for many years from the added customers. However, a pharmacy owner
considering selling the business in the next couple years should be aware that acquisition values are
based on the customer files, and many buyers are not currently willing to
include 340B customer files in their offers. This results in a lower pharmacy
business valuation and market price for the pharmacy despite the volume of
business. Also, due to the current economic conditions there are some 340B
customers who despite the deeply discounted prices, have chosen not to purchase
medications. Pharmacy owners need to consider the added costs and time of 340B
inventory and customer tracking and reporting, may not be offset by the fees
received.
If a
pharmacy owner is considering the benefits of participating in a 340B program,
or is considering selling the pharmacy in the couple years, it is advisable to
discuss the options with the pharmacy industry expert.
****************************
No comments:
Post a Comment